| INTRODUC TI ON
An association between transient receptor potential (TRP) channels and age-related diseases (e.g., cancer, Alzheimer's disease, cardiovascular disease) has been well documented (Santoni & Farfariello, 2011; Takada, Numata, & Mori, 2013; Yue et al., 2015) ; however, the specific roles of TRP channels in aging and the development of these diseases remain unclear. In a recent study, capsaicin-sensitive nociceptor TRP vanilloid 1 (TRPV1) channel activity in the peripheral sensory neurons of both mice and nematodes was shown to affect longevity and overall metabolism through Ca 2+ -dependent neuroendocrine regulation, such as the dorsal root ganglion innervation of pancreatic cells (Riera et al., 2014) . In addition, TRPV1 knockout mice exhibited pain insensitivity and increased longevity similar to those of naked mole-rats (Buffenstein, 2008; Park et al., 2008; Seluanov et al., 2009 ), which usually live for an astonishing 28 years. Naked mole-rats distinctly lack TRP pain receptors and are primarily youthful and healthy (Buffenstein, 2008) , qualities that are attributable to their characteristic pain insensitivity (Park et al., 2008) , cancer resistance (Seluanov et al., 2009) , low respiratory rate, flexible glycolytic metabolism, and low production of reactive oxygen species (ROS; Park et al., 2017) . A key link between the longevity of TRPV1 knockout mice and that of naked mole-rats is that nerve growth factor does not sensitize TRPV1 channels in naked mole-rats; furthermore, because Ca 2+ influx is reduced in naked mole-rats, inflammatory heat hyperalgesia is not induced (Omerbasic et al., 2016) .
Recently, we showed that TRPC7 is involved in ultraviolet B (UVB)-induced skin aging and diacylglycerol production in the cytoplasmic membrane and that this skin aging could be prevented by attenuating the UVB-induced elevation of intracellular Ca 2+ concentration ([Ca 2+ ] i ; Hsu et al., 2015) . The only other known physiologic function of TRPC7 reported to date is its role in the initiation of seizure activity (Phelan, Shwe, Abramowitz, Birnbaumer, & Zheng, 2014) . Thus, TRPC7 has been implicated in several pathologic processes, but little is known about TRPC7's specificity of function or the underlying mechanisms. In this study, we sought to comprehensively examine TRPC7 function in the skin. We first characterized TRPC7 as a nociceptive mechanoreceptor; then, we performed a screen in human keratinocytes to determine that, among other TRP channels, TRPC7 is uniquely involved in UVB-induced skin aging.
Furthermore, we identified an early time frame of UVB-induced TRPC7 activation and characterized its downstream effects on skin pathology over time, as well as the mechanisms underlying the effects of UVB-induced TRPC7 activation. Importantly, we show for the first time to our knowledge that TRPC7 plays a critical role in all steps of tumorigenesis, starting with the initiation of tumor formation. knockout mice also had significantly fewer UVB-induced cancerous tumors than did wild-type mice, and UVB-induced p53 gene family mutations were prevented in TRPC7 knockout mice. These results indicate that TRPC7 activity is pivotal in the initiation of UVB-induced skin aging and tumorigenesis and that the reduction in TRPC7 activity suppresses the UVB-induced aging process and tumor development. Our findings support that TRPC7 is a potential tumor initiator gene and that it causes cell aging and genomic instability, followed by a change in the activity of proto-oncogenes and tumor suppressor genes to promote tumorigenesis.
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aging, p53, TRPC7, tumor initiator gene, tumorigenesis, ultraviolet pathology F I G U R E 1 Physiologic role of TRPC7 as a nociceptive mechanoreceptor and the specificity of its cellular mechanism to the TRPC family.
(a) Calibrated von Frey filaments were used to assess mechanical hyperalgesia in wild-type (WT, n = 5) and TRPC7 −/− knockout mice (KO, n = 4). We first characterized the physiologic role of TRPC7 in the skin by using TRPC7 −/− knockout mice and found that TRPC7 is a novel mechanoreceptor that transduces mechanical pressure into pain signals ( Figure 1a ,b, and S1). Next, we examined the mechanism underlying the involvement of TRPC7 in skin aging by testing our hypothesis that TRPC7 initiates UVB-induced skin aging via [Ca 2+ ] i elevation.
To determine whether TRPC7 is the specific TRP channel involved in UVB-induced [Ca 2+ ] i elevation and the subsequent production of ROS, we performed experiments with known UVB-activated TRP channel agonists and antagonists (Table S1) (Figure 1k ,l).
| UVB-induced ROS production specifically results from TRPC7-mediated Ca 2+ influx
We then narrowed down which TRPC(s) in the skin initiate UVBinduced [Ca 2+ ] i elevation via the phospholipase C pathway. IP 3 activates TRPC1, TRPC4, and TRPC5 channels, whereas diacylglycerol activates TRPC6 and TRPC7 channels (Harteneck & Leuner, 2014) .
No difference was observed in uncaged IP 3 -mediated Ca 2+ influx in keratinocytes in the presence or absence of UVB pre-exposure (Figure 2a, b ] i elevation and ROS production began within 30 min after UVB irradiation but were inhibited by TRPC inhibitors in keratinocytes (Figure 2e,f) . Furthermore, the knockdown of TRPC7
but not TRPC6 significantly inhibited UVB-induced ROS production in keratinocytes (Figure 2g,h) . Moreover, the knockdown of TRPC7 significantly decreased Ca 2+ influx induced by the diacylglycerol analogue OAG after UVB irradiation (Figure 2i-k) . We further showed that TRPC7 was localized to the plasma membrane in keratinocytes , n = 11). Mice were exposed to UVB three times weekly. Dorsal skin and tail skin punches or clippings were sectioned for histologic and immunohistochemical analysis. (b) Photographs showing the skin's appearance. (c) Hematoxylin-and-eosin-stained images of dorsal skin and tail skin. Dotted lines indicate the boundaries of the epidermis. Quantification of the mean (± SD) epidermal thickness in (d) dorsal skin and (e) tail skin. *p < .05; **p < .01; ***p < .001. Differentiating cells were detected by using (f) keratin 10 (KRT10; keratinocytes) and (g) keratin 14 (KRT14; epidermis). (h) Ki-67 expression is shown, indicating proliferating epidermal cells (brown, counterstained with hematoxylin). Activation of the DNA damage response was analyzed by using (i) 8-oxo-2′-deoxyguanosine (8-oxodG) staining and (j) terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining. White arrows indicate cells with DNA damage. (k) Cell senescence was determined by detecting senescence-associated β-galactosidase (SA-β-gal) activity. SA-β-gal activity was reduced in the skin of TRPC7 knockout mice 2006) followed by abnormal differentiation. The shift from proliferation to differentiation may depend on the accumulation of oxidative DNA damage. Indeed, after UVB exposure, TRPC7 +/− and TRPC7 −/− mice showed less 8-oxodG and TUNEL staining in the epidermis than did wild-type mice, indicating reduced UVB-induced oxidative DNA damage and fragmentation in these mice (Figure 3i, j) . In addition, we observed the cytoplasmic expression of 8-oxodG, which is associated with malignancy (Matosevic et al., 2015) , in the dorsal skin of wild-type mice but not TRPC7 +/− or TRPC7 −/− mice after UVB exposure ( Figure 3i ).
SA-β-gal staining, used to analyze cell senescence, was also lower in the epidermis of TRPC7 +/− and TRPC7 −/− mice than in that of wild-type mice after UVB exposure (Figure 3k ). Together, these results provide evidence of a key role of TRPC7 channels in the physiologic and pathologic consequences of UVB irradiation.
| TRPC7 mediates UVB-induced epidermal aging in mice
We found that after UVB irradiation, the knockdown of TRPC7 in ke- (COX-2) expression, which increases p53 pathway activation and promotes the aging process (Hsu et al., 2015; Kim et al., 2016) . We found that after UVB exposure, the high levels of COX-2 protein expression observed in the epidermis of wild-type mice were decreased to minimal levels in TRPC7 +/− and TRPC7 −/− mice (Figure 4h ).
Although the DDR and cellular senescence are involved in the intermediate stages of the aging process, an imbalance of proliferation and apoptosis together with the accumulation of senescent and apoptotic cells results in cell aging (Cerella, Grandjenette, Dicato, & Diederich, 2016) . We found that UVB exposure increased the levels of γH2AX, p16INK4A, and cleaved caspase-3 in the epidermis of wild-type mice, indicating increased senescence and apoptosis. 
| TRPC7 mediates UVB-induced tumor initiation and growth
Aging promotes hyperplastic pathologies, with cancer being one of the most serious (Campisi, 2013) . We investigated whether interrupting UVB-induced skin aging via the knockout of TRPC7 reduced UVB-induced skin tumorigenesis in mice. Aging-associated tumorigenesis is dependent on the activation of the senescenceassociated secretory phenotype (SASP; Watanabe, Kawamoto, Ohtani, & Hara, 2017) . We found that UVB-induced SASP activation was reduced in the epidermis of TRPC7 +/− and TRPC7 −/− mice ( Figure S3 ). In normal keratinocytes exposed to UVB, the p53 family of proteins is activated, and tissue repair is initiated (Campisi, 2013) . Despite repeated UVB irradiation for 10 weeks and epidermal thickening at 1 week, the epidermis in all UVB-exposed mice was repaired and restored to a single layer at the 10th week, resembling nonirradiated skin ( Figure S4 ). Once the repair system no longer provides sufficient recovery from injury, however, the aging process begins to advance in the damaged tissue, and the epidermis thickens. In TRPC7 +/− and TRPC7 −/− mice, we observed the attenu- (Table S2 ). Furthermore, TRPC7 was found to be overexpressed in tumor biopsies from patients with non-small cell lung cancer ( Figure S5 ). The overexpression of TRPC7 that we observed in tumors from mouse and humans raises the possibility that TRPC7 promotes tumorigenesis.
| UVB-induced p53 mutations are prevented in TRPC7 knockout mice
To examine how TRPC7 affects UVB-induced tumorigenesis, we performed whole-exome sequencing in the dorsal skin of mice to characterize genetic mutations. We found that TRPC7 +/− and TRPC7 −/− mice had the smallest percentage of mutations, despite being exposed to UVB (Figure 6a ). Further analysis did not reveal significant differences between groups (Figure 6b ), but UVB-exposed TRPC7 +/− and TRPC7 −/− mice consistently had fewer mutations of each variant type than did UVB-exposed wild-type mice (Figure 6c ). Whole-exome sequencing also showed that TRPC7 +/− and TRPC7 −/− mice had a lower number of mutations than did wild-type mice (Figure 6d ). 
| D ISCUSS I ON
In this study, we show evidence for a role of TRPC7 as a potential tumor initiator gene in UVB-induced epidermal aging and skin tumorigenesis. After UVB irradiation, the increased level of diacylglycerol in the cell membrane immediately activates TRPC7 (Hsu et al., 2015) , Schematic representation of how UVB-induced epidermal aging is restrained by blocking TRPC7. UVB-activated Ca 2+ influx via TRPC7
initiates epidermal aging via an increase in Ca 2+ -induced oxidative stress with p53 activation, oxidative DNA damage and fragmentation, cell senescence, abnormal differentiation, and apoptosis. This process is inhibited by TRPC inhibitors SKF, 2-APB, and Na DNA. N, nucleus; Mt, mitochondria; ROS, reactive oxygen species and increased Ca 2+ influx from TRPC7 in turn further upregulates TRPC7 levels (Figure 4e ). Several Ca 2+ -dependent transcription factors, such as nuclear factor (NF)-κB, cAMP response element binding protein, and nuclear factor of activated T cells protein may be involved in controlling TRPC7 upregulation to amplify its activation.
Nonetheless, our findings indicate that TRPC7 induces Ca 2+ influx to produce a snowball effect that triggers several signaling pathways to initiate epidermal ROS production, inflammation, DNA damage, senescence, and cell aging. The function of TRPC7 as a potential tumor initiator gene is supported by our findings that it initiates tumor progression by causing cell aging and genomic instability, followed by a change in the activity of proto-oncogenes and tumor suppressor ) for up to 43 weeks. UVB exposure was administered once every 2 days for 43 weeks. At week 29, the carcinogens phorbol myristate acetate (PMA, 7.5 μg) and 7,12-dimethylbenz(a)anthracene (DMBA, 50 μg) were injected to promote tumor growth. (b) At week 43, dorsal skin and tail skin clippings were sectioned and stained with hematoxylin and eosin. The quantification of the mean (± SD) epidermal thickness in (c) dorsal and (d) tail skin. (e) Tumor formation, including epidermal papilloma and hypodermal sarcoma, was observed in the skin near the carcinogen injection sites. (f) Tumor prevalence and (g) tumor volume (mean ± standard error of the mean) increased with time in all groups of mice but were significantly reduced at 43 weeks in knockout mice compared with wild-type mice. The expression of (h) KRT10, (i) KRT14, (j) senescenceassociated β-galactosidase (SA-β-gal), and (k) TRPC7 is shown in mouse dorsal skin at the boundary between the epidermis and tumor. *p < .05; **p < .01; ***p < .001 genes to promote tumorigenesis. We show for the first time to our knowledge that TRPC7 is a nociceptive mechanoreceptor that actively participates in all stages of tumorigenesis. This provides a mechanistic link between TRP channels and their putative roles in cancer metastasis by altering cellular Ca 2+ homeostasis (Fels, Bulk, Petho, & Schwab, 2018) .
F I G U R E 6 TRPC7 knockout reduced the number of gene mutations in ultraviolet B (UVB)-induced tumorigenesis. Whole-exome
sequencing was used to analyze the number of mutations in the dorsal skin of UVB-exposed wild-type (WT) and TRPC7 knockout mice (n = 3). Merged data from whole-exome sequencing indicated (a) the number of mutations, (b) the contribution of each variant type, and (c) the number of mutations of each variant type. (d) A heat map illustrates the number of mutations from UVB-induced tumorigenesis, (e) the mutations specific to the TRP gene family, and (f) the p53 family genes and p53-dependent molecules. (g) Schematic representation of the role of TRPC7 as a potential tumor initiator gene in ultraviolet B (UVB)-induced aging and cancer progression. UVB-activated TRPC7 initiates UVB-induced skin aging via intracellular Ca 2+ elevation, resulting in oxidative stress, DNA damage response (DDR) activation, abnormal differentiation, and senescence inflammation response (SIR) activation; this pathology is repaired with the activation of p53 to maintain tissue homeostasis. When homeostasis is no longer maintained and the aging process is activated, carcinogens promote cancer progression. TRPC7 initiates tumorigenesis by causing genomic instability, thereby changing the activity of proto-oncogenes and tumor suppressor genes. TRPC7 is also overexpressed in cancer progression, which may promote the cell cycle and cytoskeletal remodeling by increasing Ca 2+ signaling
According to the theory of tumorigenesis, the DDR triggers the senescence inflammation response (SIR) and SASP activation, and genomic instability results in the activation of oncogenes and the dysfunction of tumor suppressor genes (Pribluda et al., 2013) . SIRinduced p53 gene family activation drives the DNA repair system to recover from genomic instability and maintain tissue homeostasis;
however, the dysfunction of p53 family genes (or tumor suppressor genes) that results from genomic instability can promote tumorigenesis . Treatment with nonsteroidal anti-inflammatory drugs as tumor preventive agents restrains tumorigenesis by blocking inflammation (Gurpinar, Grizzle, & Piazza, 2014) . Although the activation of p53 family genes drives tissue homeostasis, the repeated oncogenic stress from UVB irradiation breaks the balance between genomic instability and the DNA repair system (Pribluda et al., 2013) , and Ca 2+ signals from UVB-activated TRPC7 initiate tumorigenesis through genomic instability. Furthermore, senescence stimulates tumor formation via SASP activation (Figure 6g ).
Tumorigenesis, however, is a complex process, and several other tumor initiator genes may be involved in regulating UVB-induced tumor development. Although the blockage of TRPC7 inhibits tumor initiation, it cannot completely prohibit tumor formation.
Our discovery that TRPC7 is a nociceptive mechanoreceptor, together with our previous finding that TRPC7 has a role in UVBinduced skin aging via increased ROS production (Hsu et al., 2015) , is consistent with the previously reported links between nociceptive TRP receptors and aging (Buffenstein, 2008; Park et al., 2008; Riera et al., 2014; Seluanov et al., 2009 ). Interestingly, TRP channel expression has been previously shown to increase with age-related degeneration (Santoni & Farfariello, 2011; Takada et al., 2013; Yue et al., 2015) , but our results suggest that TRP channels, especially nociceptive TRP channels, are also important in initiating the aging process. Nociceptive TRP channels respond to environmental stimuli, such as pain, cold, or heat (Venkatachalam & Montell, 2007) . The process of aging and age-associated diseases may be due to excess Ca 2+ signaling from active nociceptors upon continual environmental stimuli. Interestingly, we found that 55.8% of gene mutations occurred through the natural process of skin aging, but only UVB treatment facilitated the induction of tumorigenesis (Figure 6a ). This supports that mutations occur during the natural process of skin aging but that an external trigger such as UVB is required for aging-associated diseases. According to our study, environmental stimulus with UVB activates TRPC7, which is pivotal to the initiation of tumorigenesis associated with skin aging. (Kunzelmann, 2005; Lehen'kyi, Shapovalov, Skryma, & Prevarskaya, 2011 TRPC7 is important to maintain tumorigenesis, malignant cells potentiate intensive epigenetic regulation and mutation according to the evolution of a tumor (Coyle, Boudreau, & Marcato, 2017) . In our study, we found that TRPC7 upregulation in tumors promotes tumor growth and also maintains genomic instability. Additionally, in TRPC7 knockout mice, p53 was protected from mutations because of the disruption of cell senescence. These results suggest that the expression of mutated p53 may be mediated through epigenetic regulation by UVB-activated TRPC7. Epigenetic reactivation of tumor suppressor genes can be determined by Ca 2+ signaling, and targeting epigenetic pathways is a potential approach for cancer therapy (Raynal et al., 2016) . Therefore, it is conceivable that, after the UVB-induced mutation of p53, the expression of mutated p53 is suppressed epigenetically, and the TRPC7-mediated epigenetic reactivation of mutated p53 in turn promotes tumorigenesis.
In conclusion, we examined the mechanism underlying cancer resistance and longevity resulting from reduced nociceptive TRP channel expression (Riera et al., 2014) . Although nociceptive TRP channels transduce stimulation into neuronal impulses for perception, they are also "first responders," with an influx of Ca 2+ to protect tissue against harm from extreme mechanical pressure, temperature, or irradiation. Consistent with this first responder role of TRP channels, our results show that harmful UVB exposure induces Ca 2+ influx through nociceptive TRPC7 channels. TRPC7 activation, however, also initiates skin aging, results in mutations in the p53 gene family, and promotes the development of cancerous tumors. Indeed, our findings suggest that TRPC7 is a potential tumor initiator gene in tumorigenesis. Finally, our results may explain why the blocking or lack of nociceptive TRP channels facilitates pain relief, cancer resistance, and longevity.
| MATERIAL S AND ME THODS

| Chemicals
Thapsigargin (TG), 2-aminoethoxydiphenyl borate (2-APB), H 2 O 2 , icilin, ATP, 1-oleoyl-2-acetyl-sn-glycerol (OAG), SKF96365, LaCl 3 , ethylenediaminetetraacetic acid (EDTA), dihydroethidium (DHE), phorbol myristate acetate (PMA), 7,12-dimethylbenzathracene (DMBA), and all other reagents were purchased from Sigma-Aldrich. Fluo-4-AM and caged IP 3 were purchased from Thermo Fisher Scientific.
| Cell culture
Human primary keratinocytes were purchased from Lonza.
Keratinocytes were incubated at 37°C in humidified 5% CO 2 in serum-free keratinocyte growth medium supplemented with human recombinant epidermal growth factor, bovine pituitary extract (5 μg/ml each), human insulin-like growth factor I (1 μg/ml), and hydrocortisone (5 μg/ml; Gibco BRL).
| Calcium imaging
To examine which TRP channels were involved in UVB-induced Ca 
| Focal IP 3 uncaging
Caged IP 3 was uncaged by using photolysis with UV light (300-400 nm) to investigate the activation of TRPC1, TRPC4, and TRPC5.
For photolytic uncaging, an Olympus FV1000 MPE multiphoton laser scanning microscope equipped with an argon laser was used to produce a collimated light beam as the principal uncaging laser line at λ = 408 nm. To detect the effect of IP 3 on TRPC Ca 2+ responses, keratinocytes were plated on 2.4-mm coverslips in a 4-cm dish.
After 50 mg/cm 2 UVB irradiation, cells were pretreated with 2 μM caged IP 3 for 30 min and stained with the Ca 2+ dye Fluo-4 to analyze changes in intracellular Ca 2+ levels. Ca 2+ -induced fluorescence was observed using an Olympus FV1000 laser scanning microscope.
Caged IP 3 was uncaged via illumination with UV light (λ = 408 nm), and IP 3 molecule released was immediately available to bind IP 3 receptors and TRPCs.
| Intracellular ROS measurement
Cells were stained with 5 μM dihydroethidium (free radical indicator), and the intensity of emitted fluorescence was analyzed by using an Olympus FV1000 laser scanning microscope.
| Quantitative reverse transcription-polymerase chain reaction (qRT-PCR)
After transfection with each siRNA (control siRNA, siTRPC1, si-TRPC4, siTRPC5, siTRPC6, and siTRPC7) for 24 hr, total RNA was extracted from keratinocytes by using TRIzol reagent (Thermo Fisher Scientific). Complementary DNA was synthesized from RNA (senescence marker; Sigma-Aldrich), caspase-3 (activated form, apoptosis mediator; GeneTex), interleukin-6 (IL-6; GeneTex), tumor necrosis factor alpha (TNF-α; GeneTex), or regulated upon activation normal T cell express sequence (RANTES, also known as CCL5;
GeneTex) were used to detect target molecules. Immunoreactivity was visualized after incubation with 3,3′diaminobenzidine (DAB) substrate-chromogen solution (DAKO) according to the manufacturer's protocol.
| Immunofluorescence staining
Fixed keratinocytes or paraffin-embedded skin sections were incubated with primary antibodies against TRPC7 (GeneTex), KRT10
(keratin 10; Proteintech), KRT14 (keratin 14; Proteintech), 8-oxodG (8-hydroxy-2′-deoxyguanosine; Abcam), or SA-β-gal (senescence-associated β-galactosidase; Abcam) at 4°C overnight. Cells or skin sections were subsequently incubated with secondary antibody for 1 hr and then with 4′,6-diamidino-2-phenylindole (DAPI, Thermo Fisher Scientific) for 5 min. Tissue was mounted on coverslips that were then inverted and fixed onto glass slides by using antifade mounting reagent (Biotium). Fluorescence imaging was performed by using a confocal microscope (Olympus FV1000).
| Western blot analysis
Western blot analysis was performed with whole-cell lysates. 
| TRPC knockdown in human keratinocytes
For TRPC knockdown experiments, human primary keratinocytes were transfected with siTRPC1, siTRPC4, siTRPC5, siTRPC6, siTRPC7, or sicontrol (Santa Cruz) constructs by using GenMute™ siRNA Transfection Reagent (SignaGen Laboratories). After transfection, healthy, subconfluent keratinocytes were cultured for 48 hr before undergoing further analysis. The expression of target genes was validated by using qRT-PCR or Western blot analysis. 
| Mechanical sensitivity
| Whole-exome sequencing
Genomic DNA was isolated from the dorsal skin of mice from each of the four groups by using Qiagen DNeasy Blood and Tissue Kit (Qiagen). The quality of the isolated DNA was examined by using an Agilent 2100 Bioanalyzer System according to the manufacturer's protocols (Agilent Technologies). DNA that passed quality control was sheared into fragments ranging from 150 to 200 bp. Ends were
repaired by using blunt-ended fragments with 5′-phosphorylated ends. Specific adaptors obtained from Illumina were ligated to the fragments by using adaptor-modified ends. The unligated adapters were removed by using AMPure XP beads, and the purified samples were amplified by using PCR with SureSelect Primer and SureSelect
Pre-capture Reverse PCR primers to generate the library for further analysis. After hybridization was performed by using the exome capture library, samples were amplified with indexed tagging primers by using PCR. The quality and quantity of the enriched library were examined by using an Agilent 2100 Bioanalyzer System and real-time PCR. The samples were then sequenced by using an Illumina Hiseq 4000 (Illumina) according to the manufacturer's standard protocols.
A total of five gigabases of DNA base-pair sequences were read, and the coverage of the whole-exome sequencing was approximately 100-fold.
| Statistical analysis
GraphPad Prism was used to generate bar charts; error bars indicated standard deviations unless otherwise noted. Analysis of variance and Student's t tests were used to compare the differences between groups. In addition, the differences between TRPC7 expression levels, clinical pathology features, and tumor prevalence were compared by using chi-squared tests. A p-value of less than .05 for the difference between groups was considered statistically significant.
ACK N OWLED G M ENTS
We 
